FARGO, North Dakota & SALT LAKE CITY, Utah--(BUSINESS WIRE)--Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for ...

Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™. VICTORIA, British Columbia--(BUSINESS WIRE)-- IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the ...

TARTU, Estonia & SALT LAKE CITY, Utah--(BUSINESS WIRE)--Icosagen Group, an established research-driven organization providing services for the discovery and production of mammalian cell-derived ...

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, announces its collaboration ...

Icosagen Group has announced that it has acquired the LSA ® platform from Carterra ®. Icosagen Cell Factory (ICF) has grown into a mammalian Contract Research, Development, and Manufacturing ...

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization ...

Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany.

Carterra ® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center (CEC) and office in Munich, Germany.

The addition of the LSA increases Icosagen's end-to-end service capabilities for drug companies developing therapeutics worldwide Icosagen Group, an established research-driven organization providing ...